Systematic review and meta-analysis of the effect of Tripterygium Glycoside Tablets on IL-23/IL-17 axis related cytokines in the treatment of rheumatoid arthritis
WANG Hanzhou1 ZHU Guangzhao2 YANG Yuzheng3 GAO Yang1 HAN Xiaochen4 SHI Bai5 HOU Jialun6 WANG Hailong1
1.Division of Rheumatology, Guang′anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China;
2.Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China;
3.Graduate School, Guizhou University of Traditional Chinese Medicine, Guizhou Province, Guiyang 550025, China;
4.Department of Internal Medicine of Thaditional Chinese Medicine, Beijing Fengsheng Hospital of Traditional Chinese Medicine Orthopedics, Beijing 100034, China; 5.Department of Endocrinology, South Area of Guang′anmen Hospital, Chinese Academy of traditional Chinese Medicine, Beijing 102600, China; 6.Human Resources Office, Beijing Foreign Studies University, Beijing 100089, China
Abstract:Objective To evaluate the effect of Tripterygium Glycoside Tablets on the expression of pro-inflammatory cytokines and anti-inflammatory cytokines related to interleukin (IL)-23/IL-17 inflammatory axis in rheumatoid arthritis (RA) treatment. Methods Search through Chinese and English databases such as CNKI, VIP, WanFang, SinoMed, EMbase, PubMed, Clinical Trials, Web of Science, Cochrane Library, etc. With a period of time from the establishment of the databases to December 22, 2019. Randomized controlled trials (RCT) of Tripterygium Glycoside Tablets for RA were included, from which the data was extracted. Methodological quality evaluation was performed using the “bias risk” assessment tool recommended by Cochrane Collaboration, and RevMan 5.3 software was used for meta-analysis. Results Compared with using Methotrexate alone, Tripterygium Glycoside Tablets combined with Methotrexate had an advantage in reducing the levels of IL-1, IL-6 and tumor necrosis factor-α, the difference were statistically significant (P < 0.05). While in comparison with using Methotrexate or Leflunomide alone, Tripterygium Glycoside Tablets combined with Methotrexate or Leflunomide had shown no statistically marked difference regarding the effect on IL-10(P > 0.05). Conclusion Tripterygium Glycoside Tablets combined with Methotrexate or Leflunomide can significantly reduce the expression of IL-23/IL-17 axis related to pro-inflammatory cytokines. However, there are rare RCTs that have reported the effect of Tripterygium Glycoside Tablets on anti-inflammatory cytokines, and the existing evidence can not reach the conclusion that Tripterygium Glycoside Tablets can improve the level of anti-inflammatory cytokines.
王翰洲1 朱光昭2 杨豫正3 高扬1 韩晓晨4 石白5 侯佳伦6 王海隆1. 雷公藤多苷片治疗类风湿关节炎作用于IL-23/IL-17轴相关细胞因子的系统评价和meta分析[J]. 中国医药导报, 2020, 17(12): 128-132.
WANG Hanzhou1 ZHU Guangzhao2 YANG Yuzheng3 GAO Yang1 HAN Xiaochen4 SHI Bai5 HOU Jialun6 WANG Hailong1. Systematic review and meta-analysis of the effect of Tripterygium Glycoside Tablets on IL-23/IL-17 axis related cytokines in the treatment of rheumatoid arthritis. 中国医药导报, 2020, 17(12): 128-132.